Premium
Administering steroids with HIV treatment‐boosting agents
Author(s) -
Singh Gurmit Kaur Jagjit,
Jones Rachael,
Shotliff Kevin
Publication year - 2017
Publication title -
prescriber
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.106
H-Index - 3
eISSN - 1931-2253
pISSN - 0959-6682
DOI - 10.1002/psb.1599
Subject(s) - medicine , boosting (machine learning) , ritonavir , cobicistat , human immunodeficiency virus (hiv) , intensive care medicine , pharmacology , virology , antiretroviral therapy , artificial intelligence , viral load , computer science
Co‐administration of a steroid with an HIV treatment‐boosting agent such as ritonavir or cobicistat increases the risk of iatrogenic Cushing syndrome and subsequent secondary adrenal suppression. This article discusses the strategies to help prevent this and describes how to identify and manage such interactions.